First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)

Title
First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD)
Authors
Keywords
Panitumumab, FOLFOX, FOLFIRI, Metastatic colorectal cancer, First-line, Liver-limited disease, Resection
Journal
EUROPEAN JOURNAL OF CANCER
Volume 81, Issue -, Pages 191-202
Publisher
Elsevier BV
Online
2017-06-20
DOI
10.1016/j.ejca.2017.04.024

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started